References
- Bokslag A, van Weissenbruch M, Mol BW, et al. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47–50.
- El-Sayed AAF. Preeclampsia: a review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol. 2017;56(5):593–598.
- Aneman I, Pienaar D, Suvakov S, et al. Mechanisms of key innate immune cells in early- and late-onset preeclampsia. Front Immunol. 2020;11:1864.
- Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
- Jido TA, Yakasai IA. Preeclampsia: a review of the evidence. Ann Afr Med. 2013;12(2):75–85.
- Li X, Wu Z, Fu X, et al. lncRNAs: insights into their function and mechanics in underlying disorders. Mutat Res Rev Mutat Res. 2014;762:1–21.
- Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491–2509.
- Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19(3):143–157.
- Jin X, Ma X, Zhu Y. Investigating Dysregulated Sub-Pathways for Preeclampsia Infants Based on lncRNA-mRNA Expression Data and Pathway Network. Ann Clin Lab Sci. 2019;49(5):598–607.
- Yang X, Meng T. Long Noncoding RNA in Preeclampsia: transcriptional Noise or Innovative Indicators? Biomed Res Int. 2019;2019:5437621.
- Yamazaki T, Souquere S, Chujo T, et al. Functional Domains of NEAT1 Architectural lncRNA Induce paraspeckle assembly through phase separation. Mol Cell. 2018;70(6):1038–1053.e7.
- Ghafouri-Fard S, Taheri M. Nuclear Enriched Abundant Transcript 1 (NEAT1): a long non-coding RNA with diverse functions in tumorigenesis. Biomed Pharmacother. 2019;111:51–59.
- Omenetti S, Pizarro TT. The Treg/Th17 Axis: a Dynamic Balance Regulated by the Gut Microbiome. Front Immunol. 2015;6:639.
- Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40(7):1830–1835.
- Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008;453(7192):236–240.
- Chang GP, Yang XL, Liu W, et al. FABP4 facilitates inflammasome activation to induce the Treg/Th17 imbalance in preeclampsia via forming a positive feedback with IL-17A. Mol Ther Nucleic Acids. 2021;24:743–754.
- Chi X, Guo Y, Zhang L, et al. Long non-coding RNA GAS5 regulates Th17/Treg imbalance in childhood pneumonia by targeting miR-217/STAT5. Cell Immunol. 2021;364:104357.
- Rambaldi MP, Weiner E, Mecacci F, et al. Immunomodulation and preeclampsia. Best Pract Res Clin Obstet Gynaecol. 2019;60:87–96.
- Jafri S, Ormiston ML. Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities. Am J Physiol Regul Integr Comp Physiol. 2017;313(6):R693–R705.
- Muyayalo KP, Huang XB, Qian Z, et al. Low circulating levels of vitamin D may contribute to the occurrence of preeclampsia through deregulation of Treg/Th17 cell ratio. Am J Reprod Immunol. 2019;82(4):e13168.
- Ding H, Dai Y, Lei Y, et al. Upregulation of CD81 in trophoblasts induces an imbalance of Treg/Th17 cells by promoting IL-6 expression in preeclampsia. Cell Mol Immunol. 2019;16(4):302–312.
- Zhang Y, Liu Z, Tian M, et al. The altered PD-1/PD-L1 pathway delivers the ‘one-two punch’ effects to promote the Treg/Th17 imbalance in pre-eclampsia. Cell Mol Immunol. 2018;15(7):710–723.
- Gast M, Rauch BH, Haghikia A, et al. Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients. Cardiovasc Res. 2019;115(13):1886–1906.
- Zhang P, Cao L, Zhou R, et al. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat Commun. 2019;10(1):1495.
- Liu R, Tang A, Wang X, et al. Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages. Int J Mol Med. 2018;42(5):2903–2913.
- Shui X, Chen S, Lin J, et al. Knockdown of lncRNA NEAT1 inhibits Th17/CD4(+) T cell differentiation through reducing the STAT3 protein level. J Cell Physiol. 2019;234(12):22477–22484.
- Teng L, Liu P, Song X, et al. Long Non-Coding RNA Nuclear-Enriched Abundant Transcript 1 (NEAT1) Represses Proliferation of Trophoblast Cells in Rats with Preeclampsia via the MicroRNA-373/FLT1 Axis. Med Sci Monit. 2020;26:e927305.
- Paraskevopoulou MD, Ag H. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
- Pan Y, Qin J, Sun H, et al. MiR-485-5p as a potential biomarker and tumor suppressor in human colorectal cancer. Biomark Med. 2020;14(3):239–248.
- Wang FR, Xu SH, Wang BM, et al. MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by targeting CX3CL1. Eur Rev Med Pharmacol Sci. 2018;22(21):7197–7204.
- Chen HO, Zhang L, Tang ZY, et al. MiR-485-5p promotes the development of osteoarthritis by inhibiting cartilage differentiation in BMSCs. Eur Rev Med Pharmacol Sci. 2018;22(11):3294–3302.
- Xu M, Wu R, Zhang L, et al. Decreased MiR-485-5p Contributes to Inflammatory Pain Through Post-Transcriptional Upregulation of ASIC1 in Rat Dorsal Root Ganglion. J Pain Res. 2020;13:3013–3022.
- Wang X, Xin S, Wang Y, et al. MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjogren’s syndrome. Bioengineered. 2021;12(1):310–324.
- Lugrin J, Martinon F. The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev. 2018;281(1):99–114.
- Man SM, Karki R, Kanneganti TD. AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity. Eur J Immunol. 2016;46(2):269–280.
- Wang B, Bhattacharya M, Roy S, et al. Immunobiology and structural biology of AIM2 inflammasome. Mol Aspects Med. 2020;76:100869.
- Sharma BR, Karki R, Kanneganti TD. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol. 2019;49(11):1998–2011.
- Li N, He F, Gao H, et al. Elevated cell-free fetal DNA contributes to placental inflammation and antiangiogenesis via AIM2 and IFI16 during pre-eclampsia. J Cell Physiol. 2020;235(12):9577–9588.